Rosiglitazone XR
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Rosiglitazone XR, covering 2016-11-07 to 2017-11-13. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers [Phase 3]